RE: The next EUA9 May 2021 14:59
Calamari - this is not the biotech sector, where every drug and treatment is different. This is mining, where commodity prices, extraction costs reserve and resource figures are all standard and known.
EUA has one mid stage exploration asset with a JORC resource of 2moz 2E PGMs (plus about 15m oz which would not even be in the inferred category under JORC). It has no DFS, no BFS and is years away from production in a hostile juristidiction with little infrastructure. This, under the theory of the bulls here, is worth £700m - £3.5bn.
SSW, to take but one example, has 400m+ oz measured and indicated, plus 500m+ inferred resource. It has huge reserves, production, cashflow, plant and equipment etc etc. It's current market cap is around £10bn. Under the theory of the bulls here, it *should* have an implied valuation of *at least* £750bn, or a 75 bagger from current prices. Similar calculations can be done for every PGM producer on the planet.